Evidence map›Paper›PMID 30706983›Full record

ArticleClinical and translational science2019

Identification and Evaluation of Clinical Substrates of Organic Anion Transporting Polypeptides 1B1 and 1B3.

Savannah J McFeely, Tasha K Ritchie, Jingjing Yu, Anna Nordmark, René H Levy, Isabelle Ragueneau-Majlessi

Abstract read
In one paragraph

Article in Clinical and translational science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Savannah J McFeelySchool of Pharmacy, University of Washington, Seattle, Washington, USA.
Tasha K RitchieSchool of Pharmacy, University of Washington, Seattle, Washington, USA.
Jingjing YuSchool of Pharmacy, University of Washington, Seattle, Washington, USA.
Anna NordmarkScandinavian Development Services, Danderyd, Sweden.ORCID 0000-0002-2628-6292
René H LevySchool of Pharmacy, University of Washington, Seattle, Washington, USA.
Isabelle Ragueneau-MajlessiSchool of Pharmacy, University of Washington, Seattle, Washington, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Organic anion transporting polypeptides (OATPs) 1B1 and 1B3 facilitate the uptake of drugs and endogenous compounds into the liver. In recent years, the impact of these transporters on drug-drug interactions (DDIs) has become a focus of research, and the evaluation of their role in drug disposition is recommended by regulatory agencies worldwide.

Indexed as

BiomarkersDrug InteractionsHumansLiver-Specific Organic Anion Transporter 1Solute Carrier Organic Anion Transporter Family Member 1B3Substrate SpecificityBiomarkersLiver-Specific Organic Anion Transporter 1SLCO1B1 protein, humanSLCO1B3 protein, humanSolute Carrier Organic Anion Transporter Family Member 1B3

Identifiers

PMID30706983
PMCPMC6662428

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.